Thermo Fisher Scientific (TMO) Interest & Investment Income (2009 - 2026)

Thermo Fisher Scientific has reported Interest & Investment Income for 15 years, with the latest figure at $207.0 million in Q2 2026.

• Interest & Investment Income for Q2 2026 came in at $207.0 million, down 30.3% year-over-year; the trailing twelve-month figure through Jun 2026 was $932.0 million (down 7.17% YoY), and the FY2025 annual result was $993.0 million, down 7.88% from the prior year.
• Interest & Investment Income slipped to $207.0 million in Q2 2026, from $233.0 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $309.0 million in Q4 2023 and troughed at $18.0 million in Q2 2022.
• A 5-year average of $203.4 million and a median of $230.0 million in 2024 frame the typical range for Interest & Investment Income.
• The widest annual swing landed in 2022, when Interest & Investment Income soared 1263.64%; it then tumbled 30.3% in 2026.
• A 5-year view of Interest & Investment Income shows it stood at $150.0 million in 2022, then surged by 106.0% to $309.0 million in 2023, then slipped by 26.54% to $227.0 million in 2024, then grew by 13.66% to $258.0 million in 2025, then slipped by 19.77% to $207.0 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $207.0 million in Q2 2026, $233.0 million in Q1 2026, and $258.0 million in Q4 2025.